Literature DB >> 11093272

CYP21 and CYP21P variability in steroid 21-hydroxylase deficiency patients and in the general population in the Netherlands.

P F Koppens1, T Hoogenboezem, H J Degenhart.   

Abstract

Steroid 21-hydroxylase deficiency is caused by defectiveness of the CYP21 gene. Such defects have presumably originated from interactions with the nearby CYP21P pseudogene during evolution. We studied these mechanisms by comparing the genetic variability of CYP21, CYP21P, and CYP21P/CYP21 hybrids (resulting from large-scale rearrangements) at eight mutation sites in a group of Dutch steroid 21-hydroxylase deficiency patients, their family members, and controls. The most common CYP21 defect in patients with salt-losing steroid 21-hydroxylase deficiency was a splice junction mutation in intron 2. The most common defect in the simple virilising form of the disease was ile72 --> asn. CYP21P showed considerable sequence variation in its central and 3' sections; the 5' section was constant. A single nucleotide (T) insert in exon 7 was found in all CYP21P genes. During the course of evolution, this was probably the third defect introduced into CYP21P after the splice junction mutation in intron 2 and the 8 bp deletion in exon 3. Gene conversions introducing CYP21-like sequences contribute to CYP21P variability. Such an event has occurred de novo in one family. A comparison of CYP21 and CYP21P mutations on the same chromosome shows that at least some of the small-scale gene conversions that supposedly transfer defects to CYP21 involve interaction between homologous chromosomes. The majority of the putative CYP21P-CYP21 transitions in hybrid genes appears to occur in a distinct zone that lies 5' of nucleotide 2108, which is further downstream than previously hypothesised. The other transitions lie upstream of nucleotide 999. Apparent 'large-scale' CYP21-CYP21P gene conversions lead to hybrid genes that are very similar to those found in CYP21 deletions, so these haplotypes have probably resulted from a meiotic double unequal crossover.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11093272     DOI: 10.1038/sj.ejhg.5200543

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  8 in total

Review 1.  The chimeric CYP21P/CYP21 gene and 21-hydroxylase deficiency.

Authors:  Hsien-Hsiung Lee
Journal:  J Hum Genet       Date:  2004-01-17       Impact factor: 3.172

2.  A unique haplotype of RCCX copy number variation: from the clinics of congenital adrenal hyperplasia to evolutionary genetics.

Authors:  Márton Doleschall; Andrea Luczay; Klára Koncz; Kinga Hadzsiev; Éva Erhardt; Ágnes Szilágyi; Zoltán Doleschall; Krisztina Németh; Dóra Török; Zoltán Prohászka; Balázs Gereben; György Fekete; Edit Gláz; Péter Igaz; Márta Korbonits; Miklós Tóth; Károly Rácz; Attila Patócs
Journal:  Eur J Hum Genet       Date:  2017-04-12       Impact factor: 4.246

3.  A rare CYP21A2 haplotype clarifies the phenotype-genotype discrepancy in an Italian patient with Non Classical Congenital Adrenal Hyperplasia (NC-CAH).

Authors:  Paola Concolino
Journal:  Mol Biol Rep       Date:  2020-03-17       Impact factor: 2.316

Review 4.  Congenital Adrenal Hyperplasia (CAH) due to 21-Hydroxylase Deficiency: A Comprehensive Focus on 233 Pathogenic Variants of CYP21A2 Gene.

Authors:  Paola Concolino; Alessandra Costella
Journal:  Mol Diagn Ther       Date:  2018-06       Impact factor: 4.074

5.  Genotype in the diagnosis of 21-hydroxylase deficiency: who should undergo CYP21A2 analysis?

Authors:  P Cavarzere; M Vincenzi; F Teofoli; R Gaudino; S Lauriola; E Maines; M Camilot; F Antoniazzi
Journal:  J Endocrinol Invest       Date:  2013-09-27       Impact factor: 4.256

6.  Novel deletion alleles carrying CYP21A1P/A2 chimeric genes in Brazilian patients with 21-hydroxylase deficiency.

Authors:  Fernanda B Coeli; Fernanda C Soardi; Renan D Bernardi; Marcela de Araújo; Luciana C Paulino; Ivy F Lau; Reginaldo J Petroli; Sofia H V de Lemos-Marini; Maria T M Baptista; Gil Guerra-Júnior; Maricilda P de-Mello
Journal:  BMC Med Genet       Date:  2010-06-29       Impact factor: 2.103

7.  Clinical profile and inheritance pattern of CYP21A2 gene mutations in patients with classical congenital adrenal hyperplasia from 10 families.

Authors:  Sarita Yadav; Shweta Birla; Eunice Marumudi; Arundhati Sharma; Rajesh Khadgawat; M L Khurana; A C Ammini
Journal:  Indian J Endocrinol Metab       Date:  2015 Sep-Oct

Review 8.  Genes and Pseudogenes: Complexity of the RCCX Locus and Disease.

Authors:  Cinzia Carrozza; Laura Foca; Elisa De Paolis; Paola Concolino
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-30       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.